Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The Phase II Trial (NCT01349959) of azacitidine combined with entinostat in TNBC showed limited clinical efficacy, despite considering epigenetic changes (e.g., reduced methylation), indicating that better results could be achieved with higher dosages or combinatorial immunotherapy [241]
However, these approaches are nonspecific to airborne viruses and often disrupt the physiological balance of the lung
You are concerned about oxidative stress or environmental toxins
and Venketaraman, V
US$ 26.04
US$ 23.38
US$ 27.52
